Rights and permissions
About this article
Cite this article
Rituximab in lymphocyte-predominant Hodgkin's disease. Inpharma Wkly. 1400, 15 (2003). https://doi.org/10.2165/00128413-200314000-00040
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200314000-00040